Schonfeld Strategic Advisors LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 158 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$102,0000.0%18,857
+7.1%
0.00%0.0%
Q3 2021$102,000
-94.6%
17,613
-90.1%
0.00%
-95.7%
Q1 2021$1,880,000
+132.1%
178,704
+318.7%
0.02%
+109.1%
Q2 2020$810,000
+180.3%
42,680
+183.9%
0.01%
-38.9%
Q1 2020$289,000
-82.7%
15,036
-82.7%
0.02%
-56.1%
Q4 2019$1,669,000
-39.1%
87,067
-69.5%
0.04%
-48.8%
Q3 2019$2,742,000
+348.0%
285,100
+172.0%
0.08%
+281.0%
Q1 2019$612,000
-46.8%
104,800
-14.7%
0.02%
-52.3%
Q4 2018$1,151,000
-83.8%
122,800
-70.6%
0.04%
-86.1%
Q3 2018$7,121,000
+0.8%
418,100
+0.6%
0.32%
-17.2%
Q2 2018$7,061,000
+44.1%
415,600
+0.7%
0.38%
+4.4%
Q1 2018$4,900,000
+104.2%
412,892
+65.2%
0.37%
+86.3%
Q4 2017$2,400,000
-12.6%
250,0000.0%0.20%
-21.5%
Q3 2017$2,745,000
-6.7%
250,000
-23.1%
0.25%
-17.2%
Q2 2017$2,941,000
-32.6%
325,000
-4.4%
0.30%
-30.8%
Q1 2017$4,366,000340,0000.44%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders